Two Sigma Securities »

Acrivon Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 12k 1.39

More positions owned by Two Sigma Securities

Ishares Tr Core Us Aggbd Et (AGG)
Amazon (AMZN)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Tesla Motors (TSLA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Tips Bd Etf (TIP)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr Gold Tr Gold Shs (GLD)
Norfolk Southern (NSC)

View all positions for Two Sigma Securities

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Wellington Management Company
Acadian Asset Management
Vanguard Capital Management
Vanguard Group
Renaissance Technologies
Marshall Wace
Acorn Capital Advisors
Two Sigma Investments
Jane Street
Geode Capital Management
BlackRock
GSA Capital Partners
Vanguard Fiduciary Trust

View all funds holding Acrivon Therapeutics